ImmuCell Corp. (ICCC)
9.75
+0.15
(+1.56%)
USD |
NASDAQ |
Oct 02, 16:00
ImmuCell Price : 9.75 for Oct. 2, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 02, 2026 | 9.80 | 9.80 | 9.61 | 9.75 | 5809.00 |
| Oct 01, 2026 | 9.80 | 9.80 | 9.551 | 9.60 | 39532.00 |
| Sep 30, 2026 | 9.885 | 9.90 | 9.735 | 9.80 | 2549.00 |
| Sep 29, 2026 | 9.92 | 10.10 | 9.92 | 9.94 | 2941.00 |
| Sep 28, 2026 | 9.78 | 10.11 | 9.69 | 9.88 | 4452.00 |
| Sep 25, 2026 | 9.96 | 9.96 | 9.670 | 9.925 | 5051.00 |
| Sep 24, 2026 | 9.96 | 10.08 | 9.96 | 9.97 | 2126.00 |
| Sep 23, 2026 | 10.03 | 10.07 | 9.85 | 9.99 | 7866.00 |
| Sep 22, 2026 | 10.10 | 10.10 | 9.805 | 9.99 | 36073.00 |
| Sep 21, 2026 | 9.80 | 10.16 | 9.74 | 10.13 | 3184.00 |
| Sep 18, 2026 | 9.80 | 9.99 | 9.68 | 9.95 | 10036.00 |
| Sep 17, 2026 | 9.615 | 9.98 | 9.56 | 9.98 | 32936.00 |
| Sep 16, 2026 | 9.63 | 9.85 | 9.46 | 9.61 | 32135.00 |
| Sep 15, 2026 | 9.75 | 9.840 | 9.50 | 9.58 | 20892.00 |
| Sep 14, 2026 | 9.80 | 9.85 | 9.71 | 9.71 | 14816.00 |
| Sep 11, 2026 | 9.91 | 9.91 | 9.634 | 9.85 | 8103.00 |
| Sep 10, 2026 | 9.84 | 10.00 | 9.765 | 9.915 | 11261.00 |
| Sep 09, 2026 | 9.81 | 9.95 | 9.79 | 9.91 | 8501.00 |
| Sep 08, 2026 | 9.82 | 10.02 | 9.80 | 9.84 | 15550.00 |
| Sep 04, 2026 | 9.97 | 9.97 | 9.80 | 9.90 | 11696.00 |
| Sep 03, 2026 | 9.90 | 10.04 | 9.90 | 10.00 | 14265.00 |
| Sep 02, 2026 | 9.825 | 10.09 | 9.825 | 10.00 | 16278.00 |
| Sep 01, 2026 | 9.85 | 10.02 | 9.835 | 9.92 | 6992.00 |
| Aug 31, 2026 | 9.86 | 10.00 | 9.77 | 9.79 | 20133.00 |
| Aug 28, 2026 | 10.30 | 10.30 | 9.89 | 9.94 | 5608.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 19.95 |
| Alnylam Pharmaceuticals, Inc. | 219.72 |
| Savara, Inc. | 4.81 |
| Vericel Corp. | 40.15 |
| Biogen, Inc. | 219.88 |
Price Related Metrics
| PE Ratio | 116.35 |
| PS Ratio | 2.887 |
| Price to Book Value | 2.822 |
| Price to Free Cash Flow | 21.01 |
| Earnings Yield | 0.86% |
| Market Cap | 88.55M |
| Operating PE Ratio | 47.45 |
| Normalized PE Ratio | 70.70 |